Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|December 15, 2002
Botox's Best Bets
Chicago - Experience using botulinum toxin type A (Botox, Botox Cosmetic) over the past few years has taught dermatologists that its utility is not equivalent across its range of potential applications, Richard G. Glogau, M.D., said.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
4
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
5